Intravenous Immunoglobulin
15-005649
Phase 3 small_molecule terminated
Quick answer
Intravenous Immunoglobulin for Autoimmune Epilepsy is a Phase 3 program (small_molecule) at Option Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Option Therapeutics
- Indication
- Autoimmune Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated